Il existe des centaines d’études scientifiques portant sur les probiotiques. Nous nous sommes appuyés notamment sur elles pour alimenter le livre "Nous avons tous beoin de probiotiques!", la nouvelle édition revue, corrigée et augmentée de "Les probiotiques c'est magique!". Voici un petit échantillon parmi les plus représentatives.
Généralités (y compris propioniques et symbiotiques)
◗ Dughera L, Elia C, Navino M, Cisarò F ; ARMONIA Study Group. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms. Acta Biomed. 2007
◗ Benno Y, Mitsuoka, Impact of Bifidobacterium longum on human fecal microflora. Microbiol.Immunol. 1992.
◗ Saavedra JM, Abi-Hanna A, et al. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr. 2004
◗ Bouglé D, Roland N, Lebeurrier F, Arhan P. Digestive and Nutritional Physiology Laboratory, CHU Caen. Effect of Propionibacteria Supplementation on Fecal Bifidobacteria and Segmental Colonic Transit Time in Healthy Human Subjets. Scand J Gastroenterol. 1999.
◗ Hoover DG. Bifidobacteria : activity and potential benefits. Food Technology. 1993.
◗ Kaneko T, Mori H, Iwata M, Meguro S. Growth stimulator for Bifidobacteria produced by Propionibacterium freudenreichii and several intestinal bacteria. Journal of Dairy Science. 1994.
◗ Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan EE, de Vos WM, Collins MD, Thiel R, Namsolleck P, Blaut M, Dore J. Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol. 2005
◗ Marteau P, Lepage P, Mangin I, Suau A, Dore J, Pochart P, Seksik P. Review article : gut flora and inflammatory bowel disease. Aliment Pharmacol Ther. 2004
◗ Mater DD, Corthier G Response of lactic acid bacteria to the digestive environment. J Clin Gastroenterol. 2004
◗ Mitsuoka T. Bifidobacteria and their role in human health. Journal of Industrial Microbiology. 1990.
◗ Mondou Francine, Harmonium International Inc., Mirabel (Québec), Canada. Activité stimulante de cultures de Propionibacterium spp sur la croissance de bifidobactéries. 2001.
◗ F. Guarner, G. Perdigon, G. Corthier, S. Salminen, B Koletzko, L. Morelli. 2005. Should yogourt be considered probiotic ? Br J Nutr. 2005.
◗ Sokol H, Lepage P, Seksik P, Dore J, Marteau P. Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut. 2007
◗ Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, Mangin I, Pochart P, Dore J, Marteau P.Review article : the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006
◗ Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J.Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach.Gut. 2006
◗ Berteau O, Guillot A, Benjdia A, Rabot S.A new type of bacterial sulfatase reveals a novel maturation pathway in prokaryotes. J Biol Chem. 2006
◗ Pablo F. Perez, Joël Doré, Marion Leclerc, Florence Levenez, Jalil Benyacoub, Patrick Serrant, Iris Segura-Roggero, Eduardo J. Schiffrin, Anne Donnet-Hughes. Bacterial imprinting of the neonatal immune system : lessons from maternal cells ? Pediatrics. 2007
◗ Mori H, Sato Y, Taketomo N, Kamiyama T, Yoshiyama Y, Meguro S, Sato K, Kaneko T. Isolation and structural identification of bifidogenic growth stimulator produced by Propionibacterium freudenreichii. Journal of Dairy Science. 1997.
◗ Romond MB, Yazourh A, Romond C. Les Bifidobacterium entre pré et probiotiques.
◗ Yaeshima. Benefits of bifidobacteria to human health. Bulletin of the IDF. 1996.
◗ Effets des probiotiques et prébiotiques sur la flore et l’immunité de l’homme adulte. Afssa. www.isapp.net/docs/AFFSAprobioticprebioticfloraimmunity05.pdf
Kéfir
◗ Encyclopaedia of Food Science, Food Technology and Nutrition, 1993
◗ T. Loretana, J.F Mosterta and B.C. Viljoen, 2003 Microbial flora associated with South African household kefir.
Rhume
◗ De Vrese M, Winkler P, Rautenberg P, et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes : a double blind, randomized, controlled trial.Clin Nutr. 2005
Diarrhées enfants
◗ Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children : a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr. 2001
◗ Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children : a meta-analysis. Pediatrics. 2002
◗ Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children : a meta-analysis. Dig Dis Sci. 2002
◗ Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Pedersen P, Tvede M, Weyrehter H, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea.Pediatr Infect Dis J. 2002
◗ Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Tvede M, Weyrehter H, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers.Pediatr Infect Dis J. 2002
◗ Gaon D, Garcia H, Winter L, Rodriguez N, Quintas R, Gonzalez SN, Oliver G. Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires). 2003
Clostridium difficile
◗ Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, Garcia RJ, Brandmarker S, Bowen K, Borjal D, Elmer GW. The search for a better treatment for recurrent Clostridium difficile disease : use of high-dose vancomycin combined with Saccharomyces boulardii.Clin Infect Dis. 2000
◗ McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z, et al. À randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994
◗ Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study : effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol. 2004
Diarrhées (associées ou non aux antibiotiques, à la radiothérapie ou à d’autres traitements)
◗ Beausoleil M, Fortier N, Guénette S et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol. 2007
◗ D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea : meta-analysis. BMJ. 2002
◗ Cremonini F, Di Caro S, Nista EC, Bartolozzi F, Capelli G, Gasbarrini G, Gasbarrini A. Meta-analysis : the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2002
◗ Gagan M. J. Review : probiotics are effective in preventing antibiotic associated diarrhoea. Evid. Based Nurs. January 1, 2003
◗ Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea : a randomized, placebo-controlled trial. Mayo Clin Proc. 2001
◗ Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.J Infect. 1998
◗ La Rosa M, Bottaro G, Gulino N, Gambuzza F, Di Forti F, Ini G, Tornambe E. Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children. À multicentric double-blind vs placebo study. Minerva Pediatr. 2003
◗ Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr. 2001
◗ Bleichner G, Blehaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. À multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med. 1997
◗ Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol. 1988
◗ Urbancsek H, Kazar T, Mezes I, Neumann K. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol. 2001
◗ Barbut Frédéric. Managing antibiotic associated diarrhoea. BMJ 2002
Colite ulcéreuse
◗ Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis : a randomised trial. Lancet. 1999
◗ Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 1997
◗ Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr. 2003
◗ Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol. 2003
◗ Cui HH, Chen CL, Wang JD, Yang YJ, Sun Y, Wang YD, Lai ZS. The effects of Bifidobacterium on the intestinal mucosa of the patients with ulcerative colitis. Zhonghua Nei Ke Za Zhi. 2003
Pouchite
◗ Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M. Prophylaxis of pouchitis onset with probiotic therapy : a double-blind, placebo-controlled trial. Gastroenterology. 2003
◗ Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis : a double-blind, placebo-controlled trial. Gastroenterology. 2000
◗ Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, Gionchetti P, Campieri M, Kamm MA. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004
Allergies (dermatite atopique, eczéma, allergies alimentaires…)
◗ Wang MF, Lin HC, et al. Treatment of perennial allergic rhinitis with lactic acid bacteria.Pediatr Allergy Immunol. 2004
◗ Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease : a randomised placebo-controlled trial. Lancet. 2001
◗ Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease : 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003
◗ Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis.J Allergy Clin Immunol. 2003
◗ Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease : underscoring the importance of viability. J Pediatr Gastroenterol Nutr. 2003
◗ Majamaa H, Isolauri E. Probiotics : a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997
Immunité
◗ Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr. 2000
◗ Meydani SN, Ha WK. Immunologic effects of yogurt. Am J Clin Nutr. 2000
◗ Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr. 2001
◗ Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, Saxelin M, Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres : double blind, randomised trial. BMJ. 2001 J
◗ Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol. 2004.
Tolérance et sécurité
◗ Saavedra JM, Abi-Hanna A, Moore N, Yolken RH. Long-term consumption of infant formulas containing live probiotic bacteria : tolerance and safety. Am J Clin Nutr. 2004
Probiotiques antalgique (comme la morphine)
◗ Communication de l’Institut national de la santé et de la recherche médicale (Inserm), 8 décembre 2006 ; Nature Medicine, Desreumaux P. et coll., 10 décembre 2006
Maladies et troubles gastro-intestinaux (y compris enfants)
◗ Gawroska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther. 2007
◗ Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 2001
Turista
◗ Hilton E, 37. Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers. J Travel Med. 1997
◗ Kollaritsch H, Holst H, Grobara P, Wiedermann G. [Prevention of traveler’s diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study]. [Article in German]. Fortschr Med. 1993
◗ Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers’ diarrhoea by Lactobacillus GG. Ann Med. 1990
◗ Rendi-Wagner P, Kollaritsch H. Drug prophylaxis for travelers’ diarrhea. Clin Infect Dis. 2002
Intestin irritable
◗ Bittner AC, Croffut RM, Stranahan MC, Yokelson TN. Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled, 1-year extension of a previously published controlled clinical trial. Clin Ther. 2007
◗ Guyonnet D, Chassany O, Ducrotte P, et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther. 2007
◗ Borowiec AM, Fedorak RN. The role of probiotics in management of irritable bowel syndrome. Curr Gastroenterol Rep. 2007
◗ Kajander K, Myllyluoma E, Rajili-Stojanovi M et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther. 2008
◗ Guslandi M. Probiotic agents in the treatment of irritable bowel syndrome. J Int Med Res. 2007
◗ Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol. 2000
◗ Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2001
◗ Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci. 2002
◗ Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2003
◗ Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME. Treatment of irritable bowel syndrome with Lacteol Fort : a randomized, double-blind, cross-over trial. Am J Gastroenterol. 1996
◗ Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000
Mycose vaginale
◗ Jeavons HS. Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus. J Obstet Gynecol Neonatal Nurs. 2003
◗ Pirotta M, Gunn J, Chondros P, Grover S, O’Malley P, Hurley S, Garland S. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis : a randomised controlled trial. BMJ. 2004
Métabolisme et cancer
◗ De Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis : a review of papers published between 1988 and 1998. Am J Clin Nutr. 2000
◗ Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol Int. 1992
◗ Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. BLP Study Group. Eur Urol. 1995
◗ Boutron MC, Faivre J, Marteau P, Couillault C, Senesse P, Quipourt V. Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis : a French case--control study. Br J Cancer. 1996
◗ Weber G, Adamczyk A, Freytag S. Treatment of acne with a yeast preparation. Fortschr Med. 1989
Surpoids
◗ Kalliomäki M, Early differences in fecal microbiota composition in children may predict overweight. American Journal of Clinical Nutrition, 2008.
◗ Role of intestinal flora in insulin resistance and obesity, Amal Yazigi 1, Bénédicte Gaborit 2, Juan Patricio Nogueira 2, Maria-Elena Butiler 2, Fabrizio Andreelli 1, La Presse Médicale, octobre 2008
◗ Les 10e Entretiens de nutrition, institut Pasteur de Lille. L’obésité, une maladie nutritionnelle ? Gut microflora : an unexpected outsider - La flore intestinale : un outsider imprévu. M. Delzenne et P. -D. Cani, Obésité, novembre 2008
◗ Une flore intestinale saine pour un métabolisme énergétique sain Healthy intestinal flora for healthy energy metabolism P.-D. Cani, J. Amar et R. Burcelin, Obésité, novembre 2007
Infection à Helicobacter (ulcère à l’estomac, etc.)
◗ Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents. 2003
◗ Wang KY, Li SN, Liu CS, Perng DS, Su YC, Wu DC, Jan CM, Lai CH, Wang TN, Wang WM. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr. 2004
◗ Linsalata M, Russo F, Berloco P, Caruso ML, Matteo GD, Cifone MG, Simone CD, Ierardi E, Di Leo A. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter. 2004
◗ Cruchet S, Obregon MC, Salazar G, Diaz E, Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition. 2003
Commentaires